IL6 and skin basal cell carcinoma: This is in agreement with the genetic inactivation of Il6ra and Stat3 function in murine models of BCC as well as with the respective in situ expression of IL6 effectors in human BCC, which together support the pathophysiological and clinical relevance of our findings.